Combining Checkpoint Inhibitors and BRAF-targeted Agents Against Metastatic Melanoma

OncoImmunology - United States
doi 10.4161/onci.24320
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited